Skip to main content
logo
Haoxi Health Technology Limited (HAO)
NASDAQ: HAO · Real-Time Price · USD
2.020
+0.100 (5.21%)
At close: Nov 9, 2026, 4:00 PM EST
2.180
+0.160 (7.92%)
After-hours: Nov 9, 2026, 6:58 PM EST

Haoxi Health Technology Income Statement

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
54.8332.848.5228.2316.16
Revenue Growth
67.14%-32.39%71.88%74.72%25.76%
Cost of Revenue
54.231.8845.7726.1715.51
Gross Profit
0.630.932.752.060.65
Selling, General & Admin
8.682.850.950.810.28
Research & Development
0.10.080.080.060.1
Operating Expenses
8.792.931.030.870.38
Operating Income
-8.16-21.721.20.27
Interest Expense
-0.05-0.05-0.04-0.02-0.01
Interest & Investment Income
0.220.360.08--
Other Non Operating Income (Expenses)
05.83-0.020.020
EBT Excluding Unusual Items
-84.151.741.190.26
Asset Writedown
-1.5----
Pretax Income
-9.54.151.741.190.26
Income Tax Expense
0.040.270.440.220.02
Net Income
-9.543.881.290.970.24
Net Income to Common
-9.543.881.290.970.24
Net Income Growth
-200.13%33.20%296.49%-19.56%
Shares Outstanding (Basic)
0----
Shares Outstanding (Diluted)
0----
Shares Change
-----
EPS (Basic)
-386.40----
EPS (Diluted)
-386.40----
EPS Growth
-----

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Free Cash Flow
-2.57-3.36-0.8-0.92-0.68
Free Cash Flow Per Share
-104.07----
Gross Margin
1.15%2.83%5.67%7.31%4.01%
Operating Margin
-14.88%-6.10%3.54%4.24%1.66%
Profit Margin
-17.39%11.82%2.66%3.44%1.51%
Free Cash Flow Margin
-4.69%-10.24%-1.65%-3.25%-4.23%
EBITDA
-7.85-1.711.731.20.27
EBITDA Margin
-14.32%-5.20%3.56%4.27%1.68%
D&A For EBITDA
0.310.290.010.010
EBIT
-8.16-21.721.20.27
EBIT Margin
-14.88%-6.10%3.54%4.24%1.66%
Effective Tax Rate
-6.53%25.56%18.54%5.78%
SEC Filings: 10-K · 10-Q